
Exhibit Hall: May 24–27, 2025, Milan, Italy
Booth # 130
Hours: 9:30 am – 4:30pm
We are excited to see you again at the ASHG annual meeting 2024!
Register for the annual meeting if you haven’t already or connect with Revvity so we can personally welcome you at our booth during the conference, on your schedule!
Full spectrum of expert NGS services and optimized workflows.
Showcasing technologies powered by your go-to names for instruments and reagents:
See you soon.
For research use only. Not for use in diagnostic procedures.
Improved rare variant analysis
NGS sequencing provides data with inherent error rates introduced during library prep which can interfere with the identification of low-abundance variants. By incorporating the NEXTFLEX™ UDI-UMI adapters on each DNA fragment prior to amplification, variant alleles present in the original sample can be distinguished confidently from errors introduced during library preparation, target enrichment, or sequencing.
Enhanced detection of low-abundance transcripts
The highly targeted DepleteX™ CRISPR-Cas9 depletion solutions remove uninformative molecules prior to sequencing and improve your ability to detect biologically relevant transcripts in single cell sequencing, whole blood samples, and even complex communities containing host and bacteria RNA.
Low-throughput DNA extraction, library prep and sample quantitation
Designed for the automated preparation of DNA libraries directly from human whole blood, the BioQule™ Bleed to Read™ DNA Library Prep Kit offers an efficient and reliable solution for genomic research. This kit allows the creation of up to 8 uniquely dual-indexed paired-end double-stranded DNA libraries with reduced hands-on time by up to 80%.
Come and meet us at ESHG 2025. We don’t want to miss this opportunity at the upcoming ESHG meeting to meet with amazing scientists from across the globe expanding research in human genetics.
Reliable and early diagnosis is the cornerstone of effective disease management. At Revvity Omics, we leverage cutting-edge technologies and a commitment to innovation to provide comprehensive solutions. Our services support clinicians and biopharma organizations in unraveling the mysteries of both common and rare diseases. Visit us at our booth to learn more about our advanced solutions for clinical genomics and pharmaceutical needs.
Reliable and early diagnosis is the cornerstone of effective disease management. At Revvity Omics, we leverage cutting-edge technologies and a commitment to innovation to provide comprehensive solutions. Our services support clinicians and biopharma organizations in unraveling the mysteries of both common and rare diseases. Visit us at our booth to learn more about our advanced solutions for clinical genomics and pharmaceutical needs.
A benchtop automated cell counter offering fast analysis and reliable cell counts with small sample volumes. The Cellometer™ Ascend™ is equipped with Matrix™ software, has multiple pre-defined assays, can analyze numerous cell types, and is 21 CFR Part 11 ready.
A benchtop automated cell counter offering fast analysis and reliable cell counts with small sample volumes. The Cellometer™ Ascend™ is equipped with Matrix™ software, has multiple pre-defined assays, can analyze numerous cell types, and is 21 CFR Part 11 ready.
An advanced and easy-to-use bead mill homogenizer, the Elite is designed for grinding, lysing, and homogenizing biological samples prior to molecular extraction. Designed with a unique carriage motion, intra-tube bead movement reduce swirling and results in high-impact bead milling that helps decrease processing time and reduces risk of sample heating.
An advanced and easy-to-use bead mill homogenizer, the Elite is designed for grinding, lysing, and homogenizing biological samples prior to molecular extraction. Designed with a unique carriage motion, intra-tube bead movement reduce swirling and results in high-impact bead milling that helps decrease processing time and reduces risk of sample heating.
A flexible, compact solution for automated nucleic extraction from diverse sample materials, the chemagic™ 360 leverages magnetic bead-based technology that offers a reliable solution to support different throughput needs and a range of downstream applications such as NGS, MPLA, genotyping, and PCR.
A flexible, compact solution for automated nucleic extraction from diverse sample materials, the chemagic™ 360 leverages magnetic bead-based technology that offers a reliable solution to support different throughput needs and a range of downstream applications such as NGS, MPLA, genotyping, and PCR.
Confirm your assays are working as expected with Revvity’s Mimix™ Reference Standards. Our Mimix control materials are cell-line derived to maintain genomic complexity and mimic patient material across molecular workflows. The blended cell lines used in our Mimix reference standards contain disease-relevant variants in key cancer genes.
Confirm your assays are working as expected with Revvity’s Mimix™ Reference Standards. Our Mimix control materials are cell-line derived to maintain genomic complexity and mimic patient material across molecular workflows. The blended cell lines used in our Mimix reference standards contain disease-relevant variants in key cancer genes.
Revvity’s Dharmacon reagents support researchers at the DNA, RNA, and protein level with the broadest range of functional genomic tools including industry leading gene modulation and gene editing solutions to help elucidate complex biological networks for functional genomic studies from single-gene experiments to whole genome screens facilitating advancements in genetic research and therapeutic discovery. Known for almost 30 years as premier providers of synthetic oligonucleotides, our Dharmacon reagents were the first to offer algorithm designed synthetic siRNA for RNAi, and the first to offer guide RNA for CRISPR-Cas9 gene editing applications.
Revvity’s Dharmacon reagents support researchers at the DNA, RNA, and protein level with the broadest range of functional genomic tools including industry leading gene modulation and gene editing solutions to help elucidate complex biological networks for functional genomic studies from single-gene experiments to whole genome screens facilitating advancements in genetic research and therapeutic discovery. Known for almost 30 years as premier providers of synthetic oligonucleotides, our Dharmacon reagents were the first to offer algorithm designed synthetic siRNA for RNAi, and the first to offer guide RNA for CRISPR-Cas9 gene editing applications.
Uncover unique phenotypes and understand protein expression on a single-cell level with TotalSeq™ oligo-conjugated antibodies. Seamlessly integrate these reagents into existing single-cell sequencing protocols for simultaneous characterization of protein and RNA or protein and DNA.
Uncover unique phenotypes and understand protein expression on a single-cell level with TotalSeq™ oligo-conjugated antibodies. Seamlessly integrate these reagents into existing single-cell sequencing protocols for simultaneous characterization of protein and RNA or protein and DNA.
The NEXTFLEX library prep reagents have optimized enzymatic and automation efficiencies to cater to our customers’ needs for cost-effective solutions to achieve robust sequencing results. They are designed to increase the flexibility and speed of library prep for customers utilizing Illumina® and Element Biosciences® sequencing platforms.
The NEXTFLEX library prep reagents have optimized enzymatic and automation efficiencies to cater to our customers’ needs for cost-effective solutions to achieve robust sequencing results. They are designed to increase the flexibility and speed of library prep for customers utilizing Illumina® and Element Biosciences® sequencing platforms.
Across the globe, there are technological gaps which can limit the scope of newborn sequencing research. With decades of laboratory expertise, Revvity’s end to end sequencing workflow – from blood spot card through final analysis – bridges these gaps, empowering newborn research beyond expectation.
Across the globe, there are technological gaps which can limit the scope of newborn sequencing research. With decades of laboratory expertise, Revvity’s end to end sequencing workflow – from blood spot card through final analysis – bridges these gaps, empowering newborn research beyond expectation.